| pubmed-article:8997575 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:8997575 | lifeskim:mentions | umls-concept:C0087111 | lld:lifeskim |
| pubmed-article:8997575 | lifeskim:mentions | umls-concept:C0035647 | lld:lifeskim |
| pubmed-article:8997575 | lifeskim:mentions | umls-concept:C0038317 | lld:lifeskim |
| pubmed-article:8997575 | lifeskim:mentions | umls-concept:C0521009 | lld:lifeskim |
| pubmed-article:8997575 | lifeskim:mentions | umls-concept:C0009763 | lld:lifeskim |
| pubmed-article:8997575 | lifeskim:mentions | umls-concept:C0005741 | lld:lifeskim |
| pubmed-article:8997575 | lifeskim:mentions | umls-concept:C0220825 | lld:lifeskim |
| pubmed-article:8997575 | lifeskim:mentions | umls-concept:C0205195 | lld:lifeskim |
| pubmed-article:8997575 | lifeskim:mentions | umls-concept:C0205191 | lld:lifeskim |
| pubmed-article:8997575 | pubmed:issue | 4 | lld:pubmed |
| pubmed-article:8997575 | pubmed:dateCreated | 1997-3-11 | lld:pubmed |
| pubmed-article:8997575 | pubmed:abstractText | The effects of four days' treatment with topical Maxitrol (neomycin sulphate 3500 IU/mL, polymyxin-B sulphate 6000 IU/mL with dexamethasone 0.1%) were compared with those of Maxidex (dexamethasone 0.1% alone) in a double-masked study in 111 patients with bacterial blepharitis or conjunctivitis, 95 of whom were evaluable for efficacy. The majority of patients (N = 80) had chronic blepharitis. Maxitrol treatment resulted in a significantly greater reduction (90%) in bacterial counts and bacterial eradication (50%) compared with Maxidex (34% and 17% respectively). Maxitrol treatment also produced a significantly greater reduction in conjunctival discharge than did Maxidex, while the treatments were equally effective in alleviating other ocular signs and symptoms. It was concluded that use of a fixed dose combination steroid-antibiotic product was more effective for bacterial control and therapeutic efficacy in the treatment of chronic blepharitis and conjunctivitis patients than treatment with steroid alone. However, in the long-term treatment of chronic blepharitis the well-known toxic problems of neomycin sulphate have to be taken into account. | lld:pubmed |
| pubmed-article:8997575 | pubmed:language | eng | lld:pubmed |
| pubmed-article:8997575 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:8997575 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:8997575 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:8997575 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:8997575 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:8997575 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:8997575 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:8997575 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:8997575 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:8997575 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:8997575 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:8997575 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:8997575 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:8997575 | pubmed:issn | 1120-6721 | lld:pubmed |
| pubmed-article:8997575 | pubmed:author | pubmed-author:StewartR HRH | lld:pubmed |
| pubmed-article:8997575 | pubmed:author | pubmed-author:MesterUU | lld:pubmed |
| pubmed-article:8997575 | pubmed:author | pubmed-author:ShulmanD GDG | lld:pubmed |
| pubmed-article:8997575 | pubmed:author | pubmed-author:SargentJ BJB | lld:pubmed |
| pubmed-article:8997575 | pubmed:issnType | Print | lld:pubmed |
| pubmed-article:8997575 | pubmed:volume | 6 | lld:pubmed |
| pubmed-article:8997575 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:8997575 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:8997575 | pubmed:pagination | 361-7 | lld:pubmed |
| pubmed-article:8997575 | pubmed:dateRevised | 2006-11-15 | lld:pubmed |
| pubmed-article:8997575 | pubmed:meshHeading | pubmed-meshheading:8997575-... | lld:pubmed |
| pubmed-article:8997575 | pubmed:meshHeading | pubmed-meshheading:8997575-... | lld:pubmed |
| pubmed-article:8997575 | pubmed:meshHeading | pubmed-meshheading:8997575-... | lld:pubmed |
| pubmed-article:8997575 | pubmed:meshHeading | pubmed-meshheading:8997575-... | lld:pubmed |
| pubmed-article:8997575 | pubmed:meshHeading | pubmed-meshheading:8997575-... | lld:pubmed |
| pubmed-article:8997575 | pubmed:meshHeading | pubmed-meshheading:8997575-... | lld:pubmed |
| pubmed-article:8997575 | pubmed:meshHeading | pubmed-meshheading:8997575-... | lld:pubmed |
| pubmed-article:8997575 | pubmed:meshHeading | pubmed-meshheading:8997575-... | lld:pubmed |
| pubmed-article:8997575 | pubmed:meshHeading | pubmed-meshheading:8997575-... | lld:pubmed |
| pubmed-article:8997575 | pubmed:meshHeading | pubmed-meshheading:8997575-... | lld:pubmed |
| pubmed-article:8997575 | pubmed:meshHeading | pubmed-meshheading:8997575-... | lld:pubmed |
| pubmed-article:8997575 | pubmed:meshHeading | pubmed-meshheading:8997575-... | lld:pubmed |
| pubmed-article:8997575 | pubmed:meshHeading | pubmed-meshheading:8997575-... | lld:pubmed |
| pubmed-article:8997575 | pubmed:meshHeading | pubmed-meshheading:8997575-... | lld:pubmed |
| pubmed-article:8997575 | pubmed:meshHeading | pubmed-meshheading:8997575-... | lld:pubmed |
| pubmed-article:8997575 | pubmed:meshHeading | pubmed-meshheading:8997575-... | lld:pubmed |
| pubmed-article:8997575 | pubmed:meshHeading | pubmed-meshheading:8997575-... | lld:pubmed |
| pubmed-article:8997575 | pubmed:meshHeading | pubmed-meshheading:8997575-... | lld:pubmed |
| pubmed-article:8997575 | pubmed:meshHeading | pubmed-meshheading:8997575-... | lld:pubmed |
| pubmed-article:8997575 | pubmed:meshHeading | pubmed-meshheading:8997575-... | lld:pubmed |
| pubmed-article:8997575 | pubmed:meshHeading | pubmed-meshheading:8997575-... | lld:pubmed |
| pubmed-article:8997575 | pubmed:meshHeading | pubmed-meshheading:8997575-... | lld:pubmed |
| pubmed-article:8997575 | pubmed:meshHeading | pubmed-meshheading:8997575-... | lld:pubmed |
| pubmed-article:8997575 | pubmed:meshHeading | pubmed-meshheading:8997575-... | lld:pubmed |
| pubmed-article:8997575 | pubmed:meshHeading | pubmed-meshheading:8997575-... | lld:pubmed |
| pubmed-article:8997575 | pubmed:meshHeading | pubmed-meshheading:8997575-... | lld:pubmed |
| pubmed-article:8997575 | pubmed:meshHeading | pubmed-meshheading:8997575-... | lld:pubmed |
| pubmed-article:8997575 | pubmed:articleTitle | Comparative evaluation of the short-term bactericidal potential of a steroid-antibiotic combination versus steroid in the treatment of chronic bacterial blepharitis and conjunctivitis. | lld:pubmed |
| pubmed-article:8997575 | pubmed:affiliation | Houston Eye Associates, Texas, USA. | lld:pubmed |
| pubmed-article:8997575 | pubmed:publicationType | Journal Article | lld:pubmed |
| pubmed-article:8997575 | pubmed:publicationType | Clinical Trial | lld:pubmed |
| pubmed-article:8997575 | pubmed:publicationType | Comparative Study | lld:pubmed |
| pubmed-article:8997575 | pubmed:publicationType | Randomized Controlled Trial | lld:pubmed |
| pubmed-article:8997575 | pubmed:publicationType | Research Support, Non-U.S. Gov't | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:8997575 | lld:pubmed |
